WATSON 409 (Lisinopril 40 mg)
Pill with imprint WATSON 409 is Yellow, Round and has been identified as Lisinopril 40 mg. It is supplied by Watson Pharmaceuticals.
Lisinopril is used in the treatment of diabetic kidney disease; heart attack; high blood pressure; heart failure and belongs to the drug class Angiotensin Converting Enzyme Inhibitors. There is positive evidence of human fetal risk during pregnancy. Lisinopril 40 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for WATSON 409
Lisinopril
- Imprint
- WATSON 409
- Strength
- 40 mg
- Color
- Yellow
- Size
- 10.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Angiotensin converting enzyme inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Watson Pharmaceuticals
- Inactive Ingredients
-
silicon dioxide,
calcium phosphate dihydrate dibasic,
FD&C Yellow No. 5,
magnesium stearate,
mannitol,
corn starch
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00591-0409 (Discontinued) | Watson Pharmaceuticals, Inc. |
| 54868-4646 (Discontinued) | Physicians Total Care Inc. (repackager) |
More about lisinopril
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Pricing & Coupons
- En Español
- 587 Reviews
- Drug class: Angiotensin Converting Enzyme Inhibitors
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.